For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a get more info debilitating condition, the arrival of Tafamidis and Tafamidis meglumine represents a true breakthrough . These innovative therapies stabilize the transthyretin protein, preventing its damaging build-up and reducing the impact of the disease . Individuals are n